CereVasc
Latest round
- Series C
Last raised
- Jun 2026
Total raised
- $198M
Investors
- 6
About CereVasc
Based in the United States, CereVasc, Inc. operates as a healthcare-focused medical device developer. The company provides minimally invasive neurological treatment solutions, including cerebrospinal fluid shunt systems and catheter-based delivery technologies., Daniel Levangie, and Patrick Sullivan, CereVasc, Inc. The company focuses on developing cerebrospinal fluid (CSF) shunt systems, notably the eShunt System, designed to treat communicating hydrocephalus. Founded by Patrick Sullivan, Daniel Levangie, Adel Malek, and Carl Heilman, the company was co-founded by its CEO, Daniel Levangie. In June 2026, CereVasc, Inc. The company works with healthcare providers, neurosurgeons, and clinical researchers to deliver minimally invasive neurological treatment solutions. Its primary offering, the eShunt System, is an investigational endovascular cerebrospinal fluid shunt designed to treat communicating hydrocephalus without invasive surgery. The system integrates implantable CSF shunts with catheter-based delivery components to enable percutaneous procedures. CereVasc’s team of engineers, clinicians, and researchers focuses on improving patient outcomes by reducing complications associated with traditional surgical interventions. Its solutions are targeted at hospitals, medical centers, and specialists managing neurological disorders globally. The company’s revenue is generated by developing and commercializing medical device solutions for neurological treatments, primarily through partnerships with healthcare institutions and distributors. CereVasc follows a B2B model, supplying its proprietary eShunt System and related technologies to hospitals and clinical providers upon regulatory approval. Future revenue streams are expected to expand through product commercialization, licensing, and distribution agreements within the healthcare ecosystem.
Who invested in CereVasc
6 investors across 3 rounds
See all investors in CereVasc
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CereVasc
Who invested in CereVasc?
CereVasc has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CereVasc raised?
CereVasc has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CereVasc last raise money?
CereVasc's most recent round on record is a Series C, in Jun 2026.
What does CereVasc do?
Based in the United States, CereVasc, Inc.
Where is CereVasc headquartered?
CereVasc is headquartered in Boston, US.
Which VCs invest in companies like CereVasc?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at CereVasc's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like CereVasc? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.